Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: inhalation

Currently viewing:

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data
Justification for type of information:
Data is from authoritative database.

Data source

Reference
Reference Type:
other: authoritative database
Title:
Acute inhalation toxicity study of 2-(3,4-dimethoxyphenyl)ethan-1-amine (120-20-7) in rat
Author:
Jay A. Brown
Year:
2017
Bibliographic source:
Haz-Map®: Information on Hazardous Chemicals and Occupational Diseases, U.S. National Library of Medicine, October 2017.

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: As mentioned below
Principles of method if other than guideline:
Acute inhalation toxicity study of 2-(3,4-dimethoxyphenyl)ethan-1-amine (120-20-7) in rat.
GLP compliance:
not specified
Test type:
other: not specified
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3,4-dimethoxyphenethylamine
EC Number:
204-376-9
EC Name:
3,4-dimethoxyphenethylamine
Cas Number:
120-20-7
Molecular formula:
C10H15NO2
IUPAC Name:
2-(3,4-dimethoxyphenyl)ethanamine
Details on test material:
Name: 2-(3,4-dimethoxyphenyl)ethan-1-amine
InChI:1S/C10H15NO2/c1-12-9-4-3-8(5-6-11)7-10(9)13-2/h3-4,7H,5-6,11H2,1-2H3
Smiles:COc1ccc(CCN)cc1OC
- Name of test material :Homoveratrylamine
- Molecular formula :C10H15NO2
- Molecular weight :181.2335 g/mol
- Substance type:organic
Specific details on test material used for the study:
Name: 2-(3,4-dimethoxyphenyl)ethan-1-amine
InChI:1S/C10H15NO2/c1-12-9-4-3-8(5-6-11)7-10(9)13-2/h3-4,7H,5-6,11H2,1-2H3
Smiles:COc1ccc(CCN)cc1OC
- Name of test material :Homoveratrylamine
- Molecular formula :C10H15NO2
- Molecular weight :181.2335 g/mol
- Substance type:organic

Test animals

Species:
rat
Strain:
not specified
Sex:
not specified
Details on test animals or test system and environmental conditions:
not specified

Administration / exposure

Route of administration:
inhalation
Type of inhalation exposure:
not specified
Vehicle:
not specified
Remark on MMAD/GSD:
not specified
Details on inhalation exposure:
not specified
Analytical verification of test atmosphere concentrations:
not specified
Duration of exposure:
4 h
Remarks on duration:
not specified
Concentrations:
5500 mg/m3 (5.5 mg/L)
No. of animals per sex per dose:
not specified
Control animals:
not specified
Details on study design:
not specified
Statistics:
not specified

Results and discussion

Preliminary study:
not specified
Effect levels
Sex:
not specified
Dose descriptor:
LC50
Effect level:
> 5 500 mg/m³ air
Based on:
test mat.
Exp. duration:
4 h
Remarks on result:
other: No mortality was observed
Mortality:
No mortality was observed at 5500 mg/m3
Clinical signs:
other: not specified
Body weight:
not specified
Gross pathology:
not specified
Other findings:
not specified

Applicant's summary and conclusion

Interpretation of results:
other: Not classified
Conclusions:
The acute inhalation toxicity dose (LC50) was considered to be >5500 mg/m3, when rats were exposed with 2-(3,4-dimethoxyphenyl)ethan-1-amine (120-20-7) by inhalation route for 4 hours.
Executive summary:

The acute inhalation toxicity study was conducted by using2-(3,4-dimethoxyphenyl)ethan-1-amine (120-20-7) in rats at concentration of 5500 mg/m3. No mortality was observed at 5500 mg/m3. Therefore, LC50 was considered to be >5500 mg/m3, when rats were exposed with2-(3,4-dimethoxyphenyl)ethan-1-amineby inhalation route for 4 hours.